Concepedia

Anna‐Carin Sköld

AS

11

Publications

323

Citations

11

H-Index

1998

Active since

Affiliations

Uppsala University(Current)

AstraZeneca (Sweden)

Karolinska University Hospital

Karolinska Institutet

AstraZeneca (United Kingdom)

Anna‐Carin Sköld is an author at Uppsala University specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1998–2012

11

Publications

11

Postmortem Changes in Blood Concentrations of Phenytoin and Carbamazepine: An Experimental Study

Torbjörn Tomson, Anna‐Carin Sköld, Per Holmgen et al. · Therapeutic Drug Monitoring · 1998 · 51 citations

Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism

Christian Danielsson, Johan Brask, Anna‐Carin Sköld et al. · Cardiovascular Research · 2012 · 43 citations · Full text

Stage‐specific skeletal and visceral defects of the I<sub>Kr</sub>‐blocker almokalant: Further evidence for teratogenicity via a hypoxia‐related mechanism

Anna‐Carin Sköld, Katrin Wellfelt, Bengt Danielsson · Teratology · 2001 · 38 citations

Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia

Bengt Danielsson, Anna‐Carin Sköld, Alf Johansson et al. · Toxicology and Applied Pharmacology · 2003 · 38 citations

, , +9

Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species

Katrin Wellfelt, Anna‐Carin Sköld, Alf Wallin et al. · Reproductive Toxicology · 1999 · 35 citations

, , +8

Rows per page

1–5 of 11